Halozyme Therapeutics
HALO
#2397
Rank
S$8.34 B
Marketcap
$65.58
Share price
1.19%
Change (1 day)
26.78%
Change (1 year)

Halozyme Therapeutics (HALO) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : S$2.24 Billion

According to Halozyme Therapeutics's latest financial reports the company's total liabilities are S$2.24 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Halozyme Therapeutics - Total liabilities on balance sheet (from 2002 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31S$2.17 B-2.8%
2022-12-31S$2.24 B82.67%
2021-12-31S$1.22 B116.23%
2020-12-31S$0.56 B-11.23%
2019-12-31S$0.63 B144.5%
2018-12-31S$0.26 B-37.27%
2017-12-31S$0.41 B-2.06%
2016-12-31S$0.42 B116.74%
2015-12-31S$0.19 B19.22%
2014-12-31S$0.16 B6.72%
2013-12-31S$0.15 B46.93%
2012-12-31S$0.10 B47.82%
2011-12-31S$71.04 M-22.31%
2010-12-31S$91.44 M-7.27%
2009-12-31S$98.61 M12.71%
2008-12-31S$87.49 M33.07%
2007-12-31S$65.75 M86.35%
2006-12-31S$35.28 M820.02%
2005-12-31S$3.83 M48.84%
2004-12-31S$2.57 M454.63%
2003-12-31S$0.46 M-56.12%
2002-12-31S$1.05 M17287.99%
2001-12-31S$0 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$0.90 B-59.52%๐Ÿ‡บ๐Ÿ‡ธ USA
S$82.70 B 3,580.12%๐Ÿ‡บ๐Ÿ‡ธ USA
S$25.28 B 1,024.94%๐Ÿ‡บ๐Ÿ‡ธ USA
S$171.26 B 7,521.19%๐Ÿ‡บ๐Ÿ‡ธ USA
S$82.10 B 3,553.55%๐Ÿ‡ซ๐Ÿ‡ท France
S$145.91 B 6,392.95%๐Ÿ‡บ๐Ÿ‡ธ USA